As an inflammatory factor, IL-1 has been shown to downregulate ABCA1 in macrophages and facilitates foam cell formation. However, the molecular mechanism underlining the downregulated ABCA1 by IL-1 is still elusive. In the present study, we demonstrated that IL-1 downregulated ABCA1 but not ABCG1 at mRNA and protein levels in a time-and dose-dependent manner in THP-1 and A549 cells. IL-1 attenuated ABCA1 promoter activity through an LXR (liver X receptor)-independent pathway, since IL-1 did not alter the expression and activities of LXR␣/, and deletion of the LXR responsive element from the ABCA1 promoter failed to reverse the IL-1 effect. In contrast, NF-B inhibition by pyrrolidine dithiocarbamate and MG132 prevented the suppression of ABCA1 by IL-1. Cotransfection with ABCA1 luciferase reporter and the expression plasmids of Rel A decreased ABCA1 promoter activities. An adenovirus expressing NF-B inhibitor subunit-␣ inhibited NF-B activities and also reversed the IL-1 effect at the promoter activity and protein levels of ABCA1. In addition, IL-1 could induce the production of reactive oxygen species (ROS), and N-acetyl-L-cysteine, a scavenger of ROS, reversed the decreased level of ABCA1 induced by IL-1. H 2O2 decreased ABCA1 at the mRNA and protein levels and the promoter activity. Thus our data provide strong evidence that ROS and NF-B, but not LXR, mediate the IL-1-induced downregulation of ABCA1 via a novel transcriptional mechanism, which might play an important role of proinflammation in the alteration of lipid metabolism.interleukin-1; nuclear factor-B; reactive oxygen species INFLAMMATION, LIPID ACCUMULATION, and foam cell formation are recognized features of atherosclerosis. The acute-phase response induced by lipopolysaccharide or proinflammatory cytokines such as TNF-␣ or IL-1 (13, 19) often leads to great alterations in lipid and lipoprotein metabolism, which alter the transcription of genes that control lipid metabolism. One of these alterations is a decreased level of high-density lipoprotein (HDL) cholesterol (12, 31). HDL level is inversely correlated with the incidence of coronary artery disease (6). The protective effect of HDL against atherosclerosis is primarily a result of its function in reverse cholesterol transport, a process by which excess cell cholesterol is taken up by HDL particles. The HDL-processed cholesterol is delivered to the liver for metabolism and bile excretion.It is commonly accepted that the efflux of cholesterol from cells is caused by two different pathways: passive efflux from the cell membrane to HDL and energy-dependent and apolipoprotein-mediated efflux (41). The latter is linked to ATPbinding cassette transporter A1 (ABCA1), a 254-kDa cytoplasmic membrane protein (14). Mutations in the ABCA1 gene, discovered in patients with Tangier disease and familial HDL deficiency, cause impaired efflux of lipids, including free cholesterol and phospholipids to apolipoprotein A-I, which results in a near absence of plasma HDL. Thus ABCA1 plays a key role in main...